Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1β maturation

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Cunha, Thiago M ^a   Talbot, Jhimmy ^a   Pinto, Larissa G ^a   Vieira, Silvio M ^a   Souza, Guilherme R ^a   Guerrero, Ana T ^a   Sonego, Fabiane ^a   Verri Jr, Waldiceu A ^a,b   Zamboni, Dario S ^a   Ferreira, Sergio H ^a   Cunha, Fernando Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MYELOPEROXIDASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 18; PTGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; INFLAMMATION; INFLAMMATORY HYPERNOCICEPTION; MALE; MOUSE; NEUTROPHIL; NOCICEPTION; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; ENZYME INDUCTION; ENZYMOLOGY; METABOLISM; NOCICEPTIVE RECEPTOR; PATHOLOGY; PROTEIN PROCESSING;

ANIMALS; CASPASE 1; CHEMOKINE CXCL1; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; NOCICEPTORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957264429     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-63     Document Type: Article

References (35)

1. Cunha TM, Verri WA, Poole S, Parada CA, Cunha FQ, Ferreira SH. Pain Facilitation by Proinflammatory Cytokine Actions at Peripheral Nerve Terminals. Immune and Glial Regulation of Pain 2007, 67-83. Seattle: IASP PRESS, Sorkin L, DeLeo J, Watkins LR.
2. Ferreira SH, Nakamura M. I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 1979, 18:179-190. 10.1016/0090-6980(79)90103-5, 230542.
3. Khasar SG, Mccarter G, Levine JD. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 1999, 81:1104-1112.
4. Nakamura M, Ferreira SH. A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 1987, 135:145-153.5. 10.1016/0014-2999(87)90606-6, 2884117.
5. Verri WA, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol Ther 2006, 112:116-38.6. 10.1016/j.pharmthera.2006.04.001, 16730375.
6. Cunha TM, Verri WA, Silva JS, Poole S, Cunha FQ, Ferreira SH. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 2005, 102:1755-1760. 10.1073/pnas.0409225102, 547882, 15665080.
7. Cunha TM, Verri WA, Schivo IR, Napimoga MH, Parada CA, Poole S, et al. Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 2008, 83:824-832. 10.1189/jlb.0907654, 18203872.
8. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247. 10.1038/ni.1703, 2820724, 19221555.
9. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995, 267:2000-2003. 10.1126/science.7535475, 7535475.
10. Li P, Allen H, Banerjee S, Seshadri T. Characterization of mice deficient in interleukin-1 beta converting enzyme. J Cell Biochem 1997, 64:27-32. 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1, 9015751.
11. Wannamaker W, Davies R, Namchuk M, Pollard J, Ford P, Ku G, et al. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl- butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther 2007, 321:509-16. 10.1124/jpet.106.111344, 17289835.
12. Elford PR, Heng R, Revesz L, Mackenzie AR. Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme. Br J Pharmacol 1995, 115:601-606. 1908483, 7582478.
13. Lee KM, Kang BS, Lee HL, Son SJ, Hwang SH, Kim DS, et al. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 2004, 19:3375-3381. 10.1111/j.0953-816X.2004.03441.x, 15217394.
14. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997, 386:619-623. 10.1038/386619a0, 9121587.
15. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 1998, 856:1-11. 10.1111/j.1749-6632.1998.tb08307.x, 9917859.
16. Fantuzzi G, Dinarello CA. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999, 19:1-11. 10.1023/A:1020506300324, 10080100.
17. Luthi AU, Cullen SP, Mcneela EA, Duriez PJ, Afonina IS, Sheridan C, et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98. 10.1016/j.immuni.2009.05.007, 19559631.
18. Li WW, Guo TZ, Liang D, Shi X, Wei T, Kingery WS, et al. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain 2009, 147:277-286. 10.1016/j.pain.2009.09.032, 19853379.
19. Verri WA, Cunha TM, Parada CA, Poole S, Liew FY, Ferreira SH, et al. Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immun 2007, 21:535-543. 10.1016/j.bbi.2006.11.005, 17194566.
20. Joosten LA, Netea MG, Fantuzzi G, Koenders MI, Helsen MM, Sparrer H, et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum 2009, 60:3651-3662. 10.1002/art.25006, 19950280.
21. Guma M, Ronacher L, Liu-Bryan R, Takai S, Karin M, Corr M. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 2009, 60:3642-3650. 10.1002/art.24959, 19950258.
22. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007, 130:918-931. 10.1016/j.cell.2007.07.009, 2134986, 17803913.
23. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336. 10.1038/nm1723, 2279180, 18264108.
24. Pinto LG, Cunha TM, Vieira SM, Lemos HP, Verri WA, Cunha FQ, et al. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 2010, 148:247-256. 10.1016/j.pain.2009.11.006, 19969421.
25. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988, 334:698-700. 10.1038/334698a0, 3137474.
26. Schroder K, Tschopp J. The inflammasomes. Cell 2010, 140:821-32. 10.1016/j.cell.2010.01.040, 20303873.
27. Lamkanfi M, Dixit VM. The inflammasomes. PLoS Pathog 2009, 5:e1000510. 10.1371/journal.ppat.1000510, 2791419, 20041168.
28. Mariathasan S, Weiss DS, Newton K, Mcbride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232. 10.1038/nature04515, 16407890.
29. Broom DC, Matson DJ, Bradshaw E, Buck ME, Meade R, Coombs S, et al. Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-ben zamide, a P2X7 antagonist in animal models of pain and inflammation. J Pharmacol Exp Ther 2008, 327:620-633. 10.1124/jpet.108.141853, 18772321.
30. Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, et al. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 2006, 319:1376-1385. 10.1124/jpet.106.111559, 16982702.
31. Cunha TM, Verri WA, Vivancos GG, Moreira IF, Reis S, Parada CA, et al. An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 2004, 37:401-407. 10.1590/S0100-879X2004000300018, 15060710.
32. Cunha TM, Verri WA, Fukada SY, Guerrero AT, Santodomingo-Garzon T, Poole S, et al. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur J Pharmacol 2007, 573:221-229. 10.1016/j.ejphar.2007.07.007, 17669394.
33. Cunha TM, Dal-secco D, Verri WA, Guerrero AT, Souza GR, Vieira SM, et al. Dual role of hydrogen sulfide in mechanical inflammatory hypernociception. Eur J Pharmacol 2008, 590:127-135. 10.1016/j.ejphar.2008.05.048, 18585702.
34. Valerio DA, Cunha TM, Arakawa NS, Lemos HP, DA Costa FB, Parada CA, et al. Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. Eur J Pharmacol 2007, 562:155-163. 10.1016/j.ejphar.2007.01.029, 17320857.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.